HLN

Haleon plc
$9.18+$0.09+0.94%Price as of Nov 13, 2026, 7:31 PM ET

Key stats

Market cap
40.3B
Open
—
Day range
—
52-week range
$8.38 – $11.28
Volume
15.6M
Avg volume
22.9M

Earnings

Next earnings call Feb 25, 2027

About

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Employees
24,524